Department of Orthopaedic Surgery, Hospital for Special Surgery, New York, New York, U.S.A.
Division of Pediatric Orthopaedics, Hospital for Special Surgery, New York, New York, U.S.A.
Arthroscopy. 2021 Feb;37(2):624-634.e2. doi: 10.1016/j.arthro.2020.09.020. Epub 2020 Dec 1.
To evaluate the cost-effectiveness of a trial of nonoperative management versus early drilling in the treatment of skeletally immature patients with stable osteochondritis dissecans (OCD) of the knee.
A decision tree model was used to compare the cost-effectiveness of a trial of nonoperative management versus early drilling (within 6 weeks of the first office visit) from payer and societal perspectives over a 3-year time horizon. Relevant transition probabilities, costs (in 2019 US dollars based on Medicare reimbursement), health state utilities, and times to healing were derived from the literature. The principal outcome measure was the incremental cost-effectiveness ratio (ICER). One- and 2-way sensitivity analyses were performed on pertinent model parameters to validate the robustness of the base-case results using a conservative willingness-to-pay (WTP) threshold of $50,000 per quality-adjusted life-year (QALY). The Consolidated Health Economic Evaluation Reporting Standards checklist for reporting economic evaluations was used.
In the base-case analysis from a payer perspective, early drilling was more effective (2.51 versus 2.27 QALYs), more costly ($4,655 versus $3,212), and overall more cost-effective (ICER $5,839/QALY) relative to nonoperative management. In the base-case analysis from a societal perspective, early drilling dominated nonoperative management owing to its increased effectiveness (2.51 versus 2.27 QALYs) and decreased cost ($13,098 versus $18,149). These results were stable across broad ranges on sensitivity analysis. Based on 1-way threshold analyses from a payer perspective, early drilling remained cost-effective as long it cost less than $19,840, the disutility of surgery was greater than -0.40, or the probability of successful early drilling was greater than 0.62.
Although the traditional approach to stable OCD lesions of the knee in skeletally immature patients has been a trial of nonoperative management, our data suggest that early drilling may be cost-effective from both payer and societal perspectives.
III, economic and decision analysis.
评估非手术治疗与早期钻孔治疗膝关节骺板未闭稳定骺软骨骨软骨病(OCD)的成本效益。
采用决策树模型,从支付者和社会角度,比较非手术治疗与早期钻孔(首次就诊后 6 周内)治疗的成本效益,时间范围为 3 年。相关转移概率、成本(基于医疗保险报销的 2019 年美元)、健康状态效用和愈合时间均来自文献。主要观察指标为增量成本效益比(ICER)。对模型参数进行单因素和双因素敏感性分析,采用保守的支付意愿(WTP)阈值(每质量调整生命年 50000 美元),验证基础病例结果的稳健性。使用卫生保健经济评价报告标准清单报告经济评价。
在支付者角度的基础病例分析中,早期钻孔治疗在疗效(2.51 比 2.27 QALY)、成本(4655 美元比 3212 美元)和总体成本效益(ICER 5839 美元/QALY)方面均优于非手术治疗。在社会角度的基础病例分析中,早期钻孔治疗优于非手术治疗,因为它提高了疗效(2.51 比 2.27 QALY)和降低了成本(13098 美元比 18149 美元)。这些结果在广泛的敏感性分析中是稳定的。基于支付者角度的单因素阈值分析,只要早期钻孔治疗的成本低于 19840 美元,手术的负效用量大于-0.40,或早期钻孔成功的概率大于 0.62,早期钻孔治疗仍然具有成本效益。
尽管传统的治疗方法是对骺板未闭稳定的膝关节 OCD 病变进行非手术治疗,但我们的数据表明,从支付者和社会角度来看,早期钻孔治疗可能具有成本效益。
III,经济和决策分析。